Network biomarkers of bladder cancer based on a genome-wide genetic and epigenetic network derived from next-generation sequencing data

Medicine and Dentistry

• Biological Marker 100%
• Bladder Cancer 100%
• Epigenomics 100%
• Side Effect 50%
• Drug Combination 50%
• DNA Repair 33%
• Regulatory Mechanism 33%
• Analysis 33%
• Cell Proliferation 33%
• microRNA 33%
• Estradiol 33%
• Gefitinib 33%
• Protein 16%
• Carcinogenesis 16%
• Development 16%
• Malignant Neoplasm 16%
• Gene 16%
• Bladder 16%
• Tamsulosin 16%
• Metastatic Carcinoma 16%
• Protein-Protein Interaction 16%
• Methylation 16%
• Microarray Analysis 16%
• Cell DNA 16%
• Defence Mechanisms 16%
• Interaction Network 16%
• LY294002 16%
• Drug Response 16%
• Gene Regulatory Network 16%
• Fulvestrant 16%
• microRNA 200b 16%
• microRNA 200a 16%
• Chlorpromazine 16%
• Yohimbine 16%

Biochemistry, Genetics and Molecular Biology

• Next Generation Sequencing 100%
• Genetics 100%
• Epigenetics 100%
• Regulatory Mechanism 33%
• Cell Proliferation 33%
• DNA Repair 33%
• MicroRNA 33%
• Regulatory Network 33%
• Estradiol 33%
• Gefitinib 33%
• Development 16%
• Protein 16%
• Nested Gene 16%
• Carcinogenesis 16%
• Microarray 16%
• LY294002 16%
• Defense Mechanism 16%
• Tumor Necrosis Factor 16%
• Methylation 16%
• Derepression 16%
• Drug Response 16%
• Gene Regulatory Network 16%
• Protein-Protein Interaction Networks 16%
• Chlorpromazine 16%